Kate Selvitelli

Abstract 4817: Preclinical evaluation of a new, non-agonist ADC targetingMET-amplified tumors with a peptide-linked maytansinoid

S. Hicks, Min Li, K. C. Lai, 2019, Experimental and Molecular Therapeutics.